CGRP migraine drugs comparison

Neurology

Compare CGRP pathway therapies for migraine prevention and acute treatment. These targeted therapies block calcitonin gene-related peptide (CGRP), a key molecule in migraine. Options include monthly injections, quarterly infusions, and oral medications.

Select any two to compare side by side

All products in this comparison

ProductManufacturerRouteFrequencyKey difference
AimovigAmgen/NovartisSC injectionMonthlyFirst FDA-approved CGRP antibody; CGRP receptor blocker
AjovyTevaSC injectionMonthly or quarterlyQuarterly dosing option; CGRP ligand blocker
EmgalityEli LillySC injectionMonthlyCGRP ligand blocker; also approved for episodic cluster headache
VyeptiLundbeckIV infusionQuarterlyIV CGRP antibody; quarterly infusion; rapid onset
Nurtec ODTPfizer/BiohavenOral (dissolving tablet)Every other day (prevention) or as needed (acute)Dual prevention and acute use; oral gepant; dissolves on tongue
QuliptaAbbVieOral (tablet)DailyDaily oral gepant for prevention only
UbrelvyAbbVieOral (tablet)As needed for acute migraineOral gepant for acute treatment only; no prevention indication
ZavzpretPfizerNasal sprayAs needed for acute migraineNasal spray gepant for acute treatment; fast-acting; no oral dosing

Related guides

Denied one of these medications?

Ellen can decode your denial letter, identify why you were denied, and generate a personalized appeal, free for patients.